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Abstract. Postconfluent cultures of HT29 cells form a
heterogeneous multilayer of which >95% of the cells
are undifferentiated. In contrast, when stably adapted
to normally lethal concentrations of methotrexate
(10~-10-5 M), they form a monolayer of gobletlike
cells (Lesuffieur et al., 1990) which secrete large
quantities of mucins and display a discrete brush bor-
der with the presence of villin, dipeptidylpeptidase-IV,
and carcinoembryonic antigen. When adapted to even
higher concentrations of methotrexate (10-4 and
T
HE ability ofcertain humancolon carcinoma cell lines
to differentiate in culture into absorptive or goblet
cells has been invaluable to the study of intestinal cell
differentiation and function (for review see Rousset, 1986;
Neutra and Louvard, 1989; Zweibaum et al., 1991). The cell
line HT-29, established in 1964 by Fogh and Trempe (1975)
has been particularly useful. Since the original observation
(Pinto et al ., 1982) that HT-29 cells, which are mostly un-
differentiated in standardculture, differentiate into absorptive
cells when glucose is replaced by galactose in the medium,
a number of different laboratories have isolated differen-
tiated HT-29 subpopulations and clones. Some are ofabsorp-
tive type (Zweibaum et al., 1985 ; Wice et al., 1985; Fantini
et al., 1986; Huet et al., 1987; Laboisse et al., 1988; Hafez
et al., 1990), others are mucus secreting (Augeron and La-
boisse, 1984; Huet et al., 1987; Lesufüeur et al., 1990,1991 ;
Hafez et al., 1990) others fluid transporting (Augeron and
Laboisse, 1984; Fantini et al., 1986; Hafez et al., 1990).
These subpopulations and clones share two general features.
Firstly, the protocols used for their establishment all involve
some kind of stress, like replacement ofglucose by galactose
(Pinto et al., 1982; Wice et al ., 1985; Fantini et al., 1986;
Dudouet et al., 1987; Huet et al., 1987), hexose deprivation
(Zweibaum et al., 1985), or treatment with drugssuch as so-
dium butyrate (Augeron and Laboisse, 1984 ; Wice et al.,
1985), polyethylene glycol (Laboisse et al., 1988), metho-
trexate (Lesuffieur et al., 1990), hexamethylene bisaceta-
mide (Hafez et al., 1990), or 5-fluorouracil (Lesuffieur et
al., 1991). Secondly their phenotype remains stable when
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10-3 M) there is a shift in the pattern of differentiation
from gobletlike to dome-forming absorptive-like cells.
These cells still display an apical brush border which
expresses villin and dipeptidylpeptidase-IV, but no
longer express significant levels of mucins and car-
cinoembryonic antigen. This shift of differentiation
coincides with a sudden amplification of the gene cod-
ing for dihydrofolate reductase and an increased activ-
ity of the enzyme.
they are subcultured under standard conditions, i.e., in the
absence of stress.
These observations can be explained in two different ways.
One possibility is that the undifferentiated HT-29 cells are
like the multipotent stem cellsof the intestinal crypt (Cheng
and Leblond, 1974), and that the various treatments trigger
critical events which commit the cells to a particular dif-
ferentiated state. The other possibility is that the emergence
of the differentiated populations is the result of a selective
process. This would be consistent with the observation that
a small proportionofdifferentiated cells are observed within
standard HT-29 cultures (Lesuffieur et al., 1990), and that
the isolation of the differentiated lines is probably always as-
sociated with a substantial cell mortality.
Whatever the mechanism(s) involved, it should be noted
that, in the experiments reported so far, the shiftwas always
in the direction from mainly undifferentiated cells towards
populations stably committed to one, or even two differen-
tiated phenotypes (Huet et al ., 1987) . When HT-29 cells are
adapted to increasing concentrations of the anticancer drug
methotrexate (MTX)' they form a mixed population of ab-
sorptive and goblet cells when adapted to 10-7 M MTX,
and of goblet cells exclusively at higher concentrations
(10- 6 and 10-5 M) (Lesuffleur et al., 1990). This sequence
1. Abbreviations used in this paper: CEA, carcinoembryonic antigen;
DHFR, dihydrofolate reductase; DPP-IV, dipeptidylpeptidase-IV; ICso,
concentration of drug that causes a 50% inhibition of control cell growth;
MTX, methotrexate; SI, sucrase-isomaltase; Rr, transepithelial resistance.The Journal of Cell Biology, Volume 115, 1991
days in culture
Figure 1. Growth adaptation of HT29-MTX10-5 cells to 10-° and
10-3 M MTX. (A and B) Adaptation to 10-4M MTX. (A) Growth
curve of H729-MTX10-5 cells (passage 11) in the presence of
10'5 MMTX (0) andof the same cells cultured in thepresence of
10-° M MTX (0) and further subcultured after 28 d (P2). (B)
Growth curves of followingweekly passages (P)in thepresence of
10`^ M MTX. (C and D) Adaptation of HT29-MTX10- 4 cells to
10-3 M MTX. (C) Growth curve of HT29-MTX10-^ cells (pas-
sage 7) in the presence of 10-° M MTX (o) and of the same cells
cultured in the presence of 10-3 M MTX (e) and further subcul-
turedafter28 d(P2). (D) Growth curves of followingweekly pas-
sages (P) in the presence of 10-3 M MTX. Growth curves of
HT29-MTX101 and HT29-MTX10-3 were stable after 7 and 10
passages, respectively.
of events is compatible with aprogressive selection process
in which cells committed to both types ofdifferentiation are
resistant to 10-' M MTX, whereas only cells committed to
goblet cell differentiation are adaptableto higher concentra-
tions.
The results reported here are in sharp contrast with this
sequence of events. Indeed we show here that increasing the
concentrationfrom 10-5 to 10-^ and 10-3 M MTX unexpect-
edly results in a shift of differentiation from the goblet cell
to the absorptive phenotype. We also show that this pheno-
typic change coincides with a major genetic event, namely
a strong amplification of the gene coding for the target en-
zyme of MTX, dihydrofolate reductase (DHFR) (Jolivet et
al ., 1983).
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Figure 2. IC--o of methotrexate in parental and MTX-adapted HT
29 cells. Values are the mean of four to five determinations made
at different passages of cells stably adapted to the concentrations
of MTX indicated. SD (not shown) were <5%. Number in paren-
theses representcoefficient ofincrease as compared with theparen-
tal cells.
Materials andMethods
Cell Culture
Theparental HT29 cell line, obtained from late Dr. J. Fogh (Sloan Ketter-
ing Memorial Cancer Center, Rye, NY), was used between passages 144
and200andis referred to as HT-29. Subpopulations adaptedfrom 10-7 to
10-3 M MTXarereferred to as HT29-MTX 10-"when grown in thepres-
ence of MTX (Sigma Chemical Co., St. Louis, MI), and HT29-Rev MTX
10-" when reversed to drug-free medium. Cellswere grownin DME (Eu-
robio, Paris, France) supplemented with 10% inactivated (30 min, 56°C)
FBS (Boehringer Mannheim Biochemicals, Mannheim, Germany). All ex-
periments and maintenance of the cells were done in 25-cm2 Tflasks
(Corning Glassworks, Corning, NY) at 37°C in a 10% C02/90% air at-
mosphere. Cells were seeded at 5 x 105 cells per flask in all conditions.
For maintenance purposes, cells were passaged weekly, using0.25% tryp-
sin in 0.53 mM EDTA in PBS Ca2Mg2-free. The medium was changed
daily in all culture conditions.
Determination ofICso ofMethotrexate
Exponentially growing cells were seeded at 5 x 103 cells per well, in 96-
well microtiter plates (Falcon, Oxnard, CA), in thepresence of increasing
concentrations ofthedrug.Themedium waschanged daily. Cell growthwas
assessed after 5 d as reported (Lesuffleur et al., 1990).
Differentiation Characteristics
Indirect immunofluorescence was performed on cryostat sections of cell
layerrolls as reported (Lesuffleur et al., 1990). This method hasthedoubleFigure 3 . Cryostat sections of rolls of postconfluent cultures (day 28) of (a and b), parental HT29 cells, (c and d), HT29-MTX10-5 cells
(passage 20), and (e andf), HT29-MTX10-3 (passage 17) stained with alcian blue (left) and periodic acid Schiff (right). Note the mul-
tilayer organization of parental HT-29 cells and the presence of a few mucus-secreting cells (arrows) . Note the monolayer organization
of HT29-MTX10-s cells with all cells secreting large amounts of mucins, but the total absence of mucins in H129-MTX10-3 cells . The
same results as observed in HT29-MTX10-3 cells were observed in cultures of cells adapted to 10-° M MTX and at different passages
(up to 20) of HT29-RevMTX10~ and 10-3 cells (not shown) . Bar, 68 gym .
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141 1Figure 4 . Indirect immunofluorescence staining of cryostat sections of rolls of postconfluent cultures of HT29-MTX10-5 (left) and HT29-
MTX10-1 cells (right) with antibodies against villin (a and b), DPP-IV (c andd), CEA (e andf), and gastric mucins (g and h) . Sections
are from the same samples as in Fig . 3 . Note the presence in HT29-MTX10-5 cells of an apical expression of villin, DPRN, and CEA
and the largeamount ofmucins ofgastric immunoreactivity. Note the apical expression ofvillin andDPP-IV, the absence ofimmunoreactive
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1412advantagetovisualize, on a same section, almostthetotality ofthecelllayer
and allow the detection of both apical and intracellular proteins . Sections
were fixed with 3.5% paraformaldehyde in PBS Ca2Mg 3z-free (10 min,
room temperature) . Mouse mAbs HBB 3/775/42 and HBB 2/614/88,
specific for human small intestinal dipeptidylpeptidase-IV (DPP-IV) and
sucrose-isomaltase (SI), respectively (Hauri et al ., 1985), were a gift from
Dr. H. P . Hauri (Biocenter of the University ofBasel, Basel, Switzerland) .
Figure5 . Transmission EM of
postconfluent cultures (day28)
of MTX-adaptedHT29 cells.
Sections are perpendicular to
thebottomoftheflask (arrows) .
(a) HT29-MTX10'S cells (pas-
sage 14) showing a goblet
cell organization with the
presence, in the supranuclear
compartmentofnumerous mu-
cus droplets, and on the lu-
minalborderofadiscrete brush
border. (b) HT29-MTX10-3
cells (passage 17). Note the
monolayer and polarized or-
ganization ofthe cells with the
presence of an apical brush
border andthe absence ofmu-
cus secretionswith onlyavery
few cells, likeoneshown here,
exhibiting a few mucus drop-
lets (arrow head) . (c) Higher
magnification of the upper
compartment ofbshovingde-
tails of the junctional com-
plexes and of the brush bor-
der. Bars : (a) 2.7,um; (b) 2.5
AM; (c) 0.9 Am .
Rabbit polyclonal antibodies against porcine villin (Rubine et al ., 1985)
wereagift fromDr. D . Louvard(Institut Pasteur, Paris, France) . Polyclonal
rabbit antibodies against mucins from gastric and colonic normal human
mucosa were produced as reported (Lesufüeur et al ., 1990) . For the detec-
tion of the P-glycoprotein, product of the multidrug resistance gene (Rior-
daan et al ., 1985) we used mAbMRK-16 (Hamada and Tsuruo, 1986), a
gift of Dr. T . Tsuruo (Cancer Chemotherapy Center, Tokyo, Japan) . mAb
CEA, and the presence of only trace amounts of gastric mucins (arrow) in HT29-MTX10-3 cells . The same results as observed in HT29-
MTX10-3 cells were observed in cells adapted to 10-° MMTX, as well as in HT29-RevMTXIO-° and HT29-RevMTXIO-3 cells (not
shown) . No colonic mucin immunoreactivity was found in cells adapted to 10-5 MTX, as reported previously (Lesuffleur et al ., 1990),
nor to 10-° or 10-3MMTX (not shown) . Bar, 30 um .
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141 3Figure 6. Phase contrast microscopy of postconfluent (day 25)
HT29-RevMTX10-3 cells showing the presence of a dome . (a) Fo-
cused on monolayer. (b) Focused on top of dome . Bar, 70 Pm .
601 against colonic cancinoembryonic antigen (CEA) was purchased from
Biosys (Compi6gne, France) . Anti-rabbit fluorescein-coupled sheep an-
tiglobulins were from Institut Pasteur Productions (Maine la Coquette,
France) . Anti-mouse fluorescein-coupled rabbit antiglobulins were from
Cappel Laboratories (Cochranville, PA) . Histological staining of cryostat
sections withperiodic acidSchiffand alcianblue (pH 2.5) was done as clas-
sical . Transmission EM was performed on cells grown in 25-cm2 plastic
flasks . Samples embedded in Epon were reembedded to make sections per-
pendicular to the bottom of the flask . The activities of DPP-IV and sucrase
were measured in cell homogenates, using classical methods as previously
reported (Chantret et al ., 1988) . Results are expressed asmilliunits/mg pro-
tein. One unit is defined as the activity that hydrolyzes 1 Fcmol of substrate
per min at 37°C.
Ransepithelial ElectricalResistanceMeasurements
HT29 and HT29-RevMTX cells (first passage in drug-free medium) were
seeded at 2 x 105 cells per well on tissue culture-treated Transwell poly-
carbonate membranes, 24.5-mm dia, 0.4-pin pore size (Costar, Cambridge,
MA), modified in the laboratory for thepassage ofelectrodes . Culture con-
ditions were as described above . Electrical measurements were performed
after 30 d in culture, under sterile conditions, using the same medium, but
supplemented with 10mM Hepes and 5% FBS only. Measurements were
performed using Ag/AgCI microelectrodes (Millipore Corporation, Bed-
ford, MA) connected to a VCL 600 voltage-current clamp instrument
(Physiological Instruments, Houston, Texas) . Values were measured after
1-s current pulses (5 juA) and corrected for the resistance of empty filters .
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Table 1 . Activities ofBrush Border-associated Hydrolases
in Parental andMTX-adapted HT-29 Cells
Southern BlotAnalysis
1414
Cells adapted to MTX
Parental cells
￿
10-° M
￿
10-` M
￿
10-3 M
DPP-IV
￿
20 f 0.5
￿
111 t 2
￿
121 t 0.5
￿
128 t 2
Sucrase nd' nd nd nd
Enzyme activities were measured in the cell homogenates of late postconfluent
cultures (day 28 after seeding) . Each value is the mean of four to five determi-
nations made at different passages . Results are expressed as milliunits/mg pro-
tein . ' nd, not detectable. Similar values were observed in corresponding
HT29-RevMTX cells (not shown) .
Comparisons were made with the unpaired Student's test with P < 0.01 as
the significance level .
Dihydrofolate Reductase Bindingand ActivityAssays
Assays were performed on exponentially growing cells (5 d after seeding) .
Cells adapted to the different concentrations ofMTX were used at the first
passage in the absence of drug in order to avoid competition with MTX .
Cells were detached with trypsin and EDTA, washed three times in PBS
Ca2Mg2-free, and stored in liquid nitrogen for further studies . The cell
pellets were extracted in Tris HC1 buffer 50mM, pH 7.5, sucrose 0.25 M .
The assays were performed on 105,000 g supernatants which were stored
as aliquots at -80°C. The protein content was estimatedusing a Bio-Rad kit
(Bio-Rad, Richmond, CA) with albumin as standard . Two different assays
were run in parallel, one measuring MTX binding on DHFR, and the other
the enzyme activity. DHFR binding assay was performed according to the
method described by Kamen et al . (1983) . The final composition of the as-
say mixture was phosphate buffer 50 mM, pH 6, NADPH 0.05 mM, KCI
25mM, beta-mercaptoethanol 15 mM, albumin 5 mg/ml, [3H]methotrex-
ate 0.05 pCi (30 Ci/mmol) and sample to measure, purifiedDHFR (Sigma
Chemical Co .) or newborn rat liver extract . After 5 min of incubation at
30°C, the reaction was stopped by adding 50 pl of a charcoal suspension
(charcoal 5 mg/ml, dextran 0.5 mg/ml, albumin 2 .5 mg/ml, EDTA50 mM) .
The tubes were then centrifuged, an aliquot ofthe supernatant mixed with
Instagel (Packard Instrument Co., Downers Grove, IL), and the radioactiv-
ity measured by liquid scintillation counting . Linearity was verified with
purifiedDHFR and newborn rat liver extract . The results are expressed as
mó1 labeled MTX bound/mg protein . DHFR activity was estimated by
measuring the decrease in absorbance at 340 nm, according to a method
adapted from Bertino et al . (1964) . The composition of the assay mixture
was : Tris HCl 100 mM, pH 7 .5, beta-mercaptoethanol 10 mM, KCl 100
mM, NADPH 0.1 mM, dihydrofolate 0.1 mM, and cell extract . The assay
was performed at 30°C . Linearity with protein content was verified and rat
liver extract was run each time in parallel as internal standard . The results
are expressed as nmol/rnin/mg protein .
DNAwas prepared frompostconfluent cells (day 28) usingproteinse K and
RNaseA (Boehringer Mannheim Biochemicals) and phenol, as described
(Davis et al., 1986) . For Southern blotting (Southern, 1975), DNAs (8 Wg/
sample) were digested with restriction nuclease EcoRl (Boehringer Mann-
heim Biochemicals), electrophoresed on 0.8% agarose gel in Tris borate
EDTAbuffer (Sambrook etal ., 1989), and transferred to Hybond N (Amer-
sham Corp ., Amersham, UK) . Filters were prehybridized (3 h, 65°C) in
a solution containing 6 x SSC, 5 x Denhardt's solution, 0.5 % SDS, and
20 Fag salmon sperm DNA per ml . A human DHFR-genomicDNA insert
(ATCC CHB 203) (Anagnou et al ., 1984; Chen et al ., 1982) was obtained
from the American Type Culture Collection (Rockville, MD), and labeled
with 32P using multiprime DNA labeling system (Amersham Corp.) . Hy-
bridization with the 32P-labeled probe was done overnight at 65°C in the
same solution as prehybridization . Before autoradiography, blots were
washed at 65°C, twice in 2 x SSC, once in 2 x SSC, 0.1% SDS, and then
once in 0.1 x SSC. 1b normalize for DNA, filters were dehybridized and
rehybridized with acDNA clone forhuman sucrase-isomaltase, SI2 (Green
et al ., 1987), a gift from Dr. D. Swallow (Medical Research Council,
University College, London) . Quantitation was achieved by scanning the
bands of fluorograms, using a densitometric scanner (model Mark III CS ;
Joyce, Loebl and Co., Ltd ., Gatehead, UK) .N
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Figure 7. Transepithelial resistance (RT) of control and MTX-
adapted HT-29 cell cultures grown on filters. Results from each
population are the mean and SD ofmeasurements ofsix filtersmade
at 0, 2, 12, 24, 48, and 72 h. Values for each filter were found to
be stable from one measurement to another. RT from all MTX-
adapted populations were significantly different from control cells
(P < 0.001) with the values from HT29-MTX10-5 being signifi-
cantly different from those from the other MTX-adapted cells
(P < 0.001).
Results
Adaptation ofH729-MTXIo-5 tolo-4and10-3MMTX
The kinetics of adaptation of H'129-MTX10-5 cells to 10-
and 10'3 M MTX is shown in Fig. 1. For each concentra-
tion there is a high rate of mortality in the first days of the
first passage, followed by a slow resumption of cell growth.
The growth rate then increases progressively in the following
subcultures, until stabilization of the growth curve after sev-
eral passages (7 and 10 for cells adapted to 10-^ and 10-3 M
MTX, respectively) . This pattern of adaptation resembles
that seen in the adaptation to lower concentrations of the
drug (Lesuffleur et al., 1990). ICSo of HT29-MTX 10-^ and
H129-MTX 10-3, and comparison with the values in HT29
cellsand in subpopulations adapted to lowerconcentrations,
is reported in Fig. 2.
Dose-dependent Modification of
theDifferentiatedPhenotype
Analysis ofthe differentiation pattern of HT29 subpopulations
stably adapted to 10-' and 10-3 M MTX (H'129-MTX10-°
and H129-MTX10-I) shows a clear-cut modification of the
differentiated phenotype, compared with HT29-MTX10- 6
and 10-5 cells.
Postconfluent cultures of HT29-MTX10~ and 10-5 cells,
and of the same cells reversed to drug-free medium, form a
monolayer of polarized goblet cells. These goblet cellsall se-
crete, from the tenth to fourteenth day on, large amounts of
mucins which are positively stained with PAS and alcian
Lesufeur et al. Shift of Differentiation ofHT-29 Cells
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Figure 8. Dihydrofolate reductase measurements in parental and
MTX-adapted HT29 cells. Results of MTX binding assays are ex-
pressed as 10-° mol MTX boundper mg ofprotein. Precise values
corresponding to histograms are 1.29 t 0.06, 3.29 t 0.2, 3.06 f
0.06, 4.7 t 0.25, 25.4 t 0.8, and 276.3 t 8.5 for parental and cells
adapted to 10-', 10- 6, 10-5, 10- 4, and 10-3 M MTX, respectively.
Results of enzyme activities are expressed as nmol/min/mg of pro-
tein. Precisevalues correspondingtohistograms are 0.673 t 0.163,
1.61 t 0.063, 1.726 t 0.054, 3.546 t 0.146, 36.22 t 1.054, and
256.0 t 7.41 for parental and cells adapted to 10-7, 10- 6, 10-5,
10-°, and 10-3 M MTX, respectively.
blue (Fig. 3, c and d) and immunoreact with antibodies
against gastric, but not colonic, mucins (Fig. 4 g). They also
exhibit a discrete apical brush border (Fig. 5 a) and show an
apical expression of villin, DPP-IV, and CEA (Fig. 4, a, c,
and e). In contrast, late postconfluent cultures of HT29-
MTX 10-° and 10-3 cells are no longer of the gobletlike
type, but display an absorptive-like pattern ofdifferentiation.
They form a monolayer ofpolarized cells which form domes
(Fig. 6). The majority of these cells show no sign of mucus
secretion (Fig. 3, e andf, Fig. 4 h; and Fig. 5 b), except for
a very few cells (<0.01%) which show some discrete mucus
secretions at immunofluorescence (Fig. 4 h) and transmis-
sion EM (Fig. 5 b). These aborptive-like cells, like the cells
adapted to lower concentrations (10~ and 10-5 M), exhibit
an apical brushborder (Fig. 5, band c) which expresses vil-
lin (Fig. 4 b) and DPRIV (Fig. 4 d; Table 1) and have an
elevated transepithelial resistance (Fig. 7). However CEA is
not expressed (Fig. 4f). This differentiation pattern is sta-
ble, as it is observed in all the subsequent passages (up to
15-30) of the two subpopulations and maintained when the
cells are subcultured in drug-free medium (up to 25 pas-
sages) . Like in populations adapted to lower concentrations
of MTX (10-7 to 10-5 M) no expression of SI could be de-
tected, whether by immunofluorescence (not shown) or en-
zyme activity assays (Table 1). This absence of SI is consis-
tent with the observation that the expression of the enzyme
is repressed when HT-29 cells are grown, as in this case, in
the presence ofglucose (Huet etal., 1987; Zweibaum et al.,
1985). No P-glycoprotein could be detected either (not
shown).Figure 9. Southern blot analysis ofDNA from parental andMTX-
adapted HT29 subpopulations . DNA was extracted from post-
confluent cultures ofcells stably adapted to the corresponding con-
centrations ofMTX . Numbers correspond to parental cells (1) and
to cells adapted to MTX 10-7 M (2), 10-6 M (3), 10-5 M (4),
10-° M (5), and 10-3M (6) . (Left) Hybridization with probe CHB
203 for human DHFR (see Materials and Methods) . (Right)I.-
same filter was dehybridized and rehybridized, as control, with
probe S12 for human sucrase-isomaltase. Note the increased sig-
nals for the 13-kb band ofDHFR in lanes 5 and 6 (left) which could
not be completely dehybridized as shown in lanes 5 and 6 (right) .
Coefficients of amplification of the 13-kb band of DHFR, as
deduced from scanning analysis, were 1.1, 1.3, 2 .9, 17.4, and 52.7
for cells adapted to 10-7 , 10` 6 , 10-5 , 10-4 , and 10-3 M MTX,
respectively .
Dose-dependent Amplification ofthe DHFR Gene
The intracellular content of DHFR increases only slightly
with the first concentrations of adaptation to MTX (10-' to
10-5 M), but shows a dramatic increase at the upper con-
centrations of adaptation, reaching values which are 20 and
214 times (binding assay) and 54 and 380 times (enzyme ac-
tivity) higher than in parental cells in H'129-MTX105 and
HT29-MTX10-3 cells, respectively (Fig . 8) . This increase
ofthe enzyme content and activity parallels an amplification
ofthe DHFR gene as substantiated by Southern blot analysis
(Fig . 9) . The relationship between the dose-dependent levels
ofDHFR and the differentiation pattern of the corresponding
cultures is summarized in Fig . 10.
Discussion
We report here for the first time a shift in the pattern of
differentiation ofHT29 cells from one differentiated pheno-
type to another, i.e ., from mucus-secreting to absorptive
type cells . This change in phenotype occurs in the course of
adaptation of the cells to increasing concentrations ofMTX .
It is concomitant with a large amplification of the DHFR
gene. Amplification ofthis gene is a well-known mechanism
of acquired resistance to MTX (Schimke, 1984) . Its occur-
rence, like in the present case, is often associated with resis-
tance to very high drug concentrations (Srimatkandada et
al ., 1983, 1989) .
The reasons for the change in phenotype are unclear. A
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Figure 10 . Schematic representation of the relationship differen-
tiation pattern/DHFR activity in HT-29 cells stably adapted to
increasing concentrations of MTX . For the differentiation pat-
tern of parental, HT29-MTX10-1 , and HT29-MTX105 cells (see
Lesufeur et al ., 1990) . DHFR activity refers to the data in Fig . 8.
clonal selection of a hypothetical population of absorptive
cells present in cultures adapted to 10'6 and 10-5 M MTX
is unlikely, since one would have expected to detect popula-
tions of these cells in the course of the numerous passages
maintained at these concentrations ofMTX (at least 50) . It
is also most unlikely that the shift ofdifferentiation is adirect
consequence ofMTX "per se," as it is maintained when the
cells are subcultured in drug-free medium . However there
may be a causal relationship between the amplification ofthe
DHFR gene and the change in phenotype . DHFR is a key
enzyme in the folate cycle (Morrison and Allegra, 1989) and
the increased activity of theenzymemay result in an impair-
ment of the normal balance of intermediate metabolites and
cofactors associated with this cycle . Accordingly, the disap-
pearance of mucins simply could be a result of a decreased
availability of one of the substrates ofthe folate cycle, namely
serine, which is a major aminoacid inthe peptide core ofmu-
cins (Neutra and Forstner, 1987) . Another possibility is that
increased DHFR activity results in modifications of the pool
of 5-methyltetrahydrofolates . This might result in a change
of availability of methyl groups and therefore alterations of
DNA and RNA methylation which, in turn, may lead to
changes in differentiation (Bird, 1986 ; Jones, 1986) . Such a
mechanism could interfere with the normal expression of
genes coding for mucins and CEA, either directly, or in-directly through modifications of expression of the enzymes
involved in their glycosylation. Lastly, it cannot be excluded
that the phenotypic change observed is independent from
DHFR amplification, but results from other genetic changes
associated with drug-induced chromosomal modifications
(Bostock et al., 1979), as shown in HT-29 cells adapted to
5-fluorouracil (Lesuffleur et al., 1991).
Whatever the mechanisms, it is of interest to note that the
shift in differentiation is reminiscent of the late developmen-
tal stages of the humancolon; indeed, the midgestational co-
lonic luminal epithelium is exclusively formed of polarized
goblet cells which, like in HT29-MTX10~ and 10-5 cells,
show an apical expression of villin and brush-border hydro-
lases, whereas, in the late stages ofgestation, this epithelium
is exclusively formed of absorptive cells (Kornowski, A ., T.
Lesuffeur, Y Kedinger, A. Salmon, and A. Zweibaum,
manuscript in preparation). Interestingly, H'129-MTX mu-
cus cellsat low drug concentration have a transepithelial re-
sistance, a characteristic which has been shown to be as-
sociated with columnar absorptive cells, like Caco-2 cells
(Grasset et al ., 1984) and the transporting clone HT29-19A
(Augeron et al., 1986) . Electrical resistance has not, to our
knowledge, been studied before in cultures of mucus colonic
cells (Augeron and Laboisse, 1984 ; Huet et al., 1987) .
Whether midgestational colonic mucus cells also display
functional characteristics of absorptive cells is unknown.
Further studies on these HT-29 cells and on the mecha-
nisms responsible for the modifications observed should be
helpful in unraveling the factors which control the commit-
ment of normal intestinal cells to the alternative types of
differentiation, namely goblet or absorptive cells.
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